A carregar...
Organoprotective effects of serelaxin in patients with severe decompensated heart failure
Serelaxin (recombinant molecule of the human relaxin-2) is an innovative drug for the treatment of acute heart failure. Preclinical and clinical studies demonstrated the ability of serelaxin to relieve the symptoms of heart failure, provide a significant reduction in congestion and have a protective...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Stolichnaya Izdatelskaya Kompaniya
2016-09-01
|
| Colecção: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Assuntos: | |
| Acesso em linha: | https://www.rpcardio.com/jour/article/view/1305 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|